Home › Psoriatic Arthritis › North Carolina › Durham
Psoriatic Arthritis clinical trials in Durham, NC
4 studies for Psoriatic Arthritis are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
RecruitingPhase 1
- Up0122 102, Durham
- Up0122 106, Chapel Hill · 10 mi away
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RecruitingPhase 3
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill · 10 mi away
A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
RecruitingPhase 4
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
- Duke Children's Hospital & Health Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
About Psoriatic Arthritis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
More about Psoriatic Arthritis on MedlinePlus
Psoriatic Arthritis trials in other cities
- Houston, TX8 studies
- Charlotte, NC7 studies
- Parma, OH6 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- Altoona, PA6 studies
- Plantation, FL5 studies
- Cleveland, OH5 studies
- Clearwater, FL5 studies
- Milwaukee, WI5 studies
- San Diego, CA5 studies
- New York City, NY5 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)59 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.